Asset Details
Do you wish to reserve the book?
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
Do you wish to request the book?
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
2006
Overview
Protein drugs cannot be delivered efficiently through oral routes. To address this challenge, we evaluated the effect of prolonged gastrointestinal transit on the bioavailability of insulin carried by magnetically responsive microparticles in the presence of an external magnetic field.
Magnetite nanocrystals and insulin were coencapsulated into poly(lactide-co-glycolide) (PLGA) microparticles and their effects on hypoglycemia were evaluated in mice in the presence of a circumferentially applied external magnetic field.
A single administration of 100 U/kg of insulin-magnetite-PLGA microparticles to fasted mice resulted in a reduction of blood glucose levels of up to 43.8% in the presence of an external magnetic field for 20 h (bioavailability = 2.77 +/- 0.46 and 0.87 +/- 0.29% based on glucose and ELISA assay, respectively), significantly higher than similarly dosed mice without a magnetic field (bioavailability = 0.66 +/- 0.56 and 0.30 +/- 0.06%, based on glucose and ELISA assay, respectively).
A substantially improved hypoglycemic effect was observed in mice that were orally administered with insulin-magnetite-PLGA microparticles in the presence of an external magnetic field, suggesting that magnetic force can be used to improve the efficiency of orally delivered protein therapeutics.
Publisher
Springer,Springer Nature B.V
Subject
/ Animals
/ Biological and medical sciences
/ Drug Carriers - administration & dosage
/ Drugs
/ Ferrosoferric Oxide - chemistry
/ Glucose
/ Hypoglycemic Agents - administration & dosage
/ Hypoglycemic Agents - pharmacokinetics
/ Hypoglycemic Agents - therapeutic use
/ Insulin
/ Insulin - administration & dosage
/ Mice
/ Pharmaceutical technology. Pharmaceutical industry
/ Pharmacology. Drug treatments
/ Polyglycolic Acid - chemistry
/ Polymers
/ Proteins
